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Abstract
Diagnosis of epilepsy after a first unprovoked seizure is possible according to the guidelines by the International League
Against Epilepsy, if the risk recurrence of a second unprovoked seizure is exceeding 60%. However, this cutoff constitutes
only a proxy depending on the patients’ history, magnetic resonance imaging (MRI), and electroencephalography (EEG)
findings but nevertheless also from the treating neurologists’ individual experience. In a Switzerland-wide observational
study, we aim to recruit patients that were admitted to the emergency department with the referral diagnosis of a first and
unprovoked seizure. We make use of optimized MRI protocols to identify potential structural epileptogenic lesions,
introduce new imaging-based markers of epileptogenecity, and use most recent postprocessing methods as automatic
morphometry, spike map analysis, and functional connectivity. With these diagnostic tools, we aim to segregate patients
that present with epileptic seizures versus mimicks and non-epileptic seizures and stratify for every finding in MRI and EEG
its predictive value for a second unprovoked seizure. These findings shall support neurologists to calculate and not only
estimate the seizure recurrence rate in future.
Keywords
Epilepsy, neuroimaging, automatic morphometry, functional connectivity, spike maps
Introduction
Epilepsy affects around 0.7% of the population, that is, 60,000
patients in Switzerland (8 Mio. citizens) and each year 4000
patients add to this number.1 Isolated acute symptomatic sei-
zures (e.g. due to alcohol withdrawal) or syncopes are much
more frequent, that is, around 10% of the population. In any
case, over 90% of the patients are referred to an emergency
department (ED), where the assessment of a first seizure con-
stitutes a challenging task. The first seizure can be the first of
many others or remain the only one in the patient’s lifespan.
Differential diagnosis encompasses psychogenic events, tran-
sient ischemic attacks, migraine, metabolic, vegetative, and
cardiac events.2,3 Moreover, segregating acute symptomatic
and unprovoked seizures remains difficult, since patient’s
history can suggest provoked seizures even if there is no
causal relationship and vice versa.
Currently, there are no reliable biomarkers allowing a
correct classification of a first event as onset of epilepsy or
1Support Center for Advanced Neuroimaging, Inselspital, University of
Bern, Bern, Switzerland
2Sleep-Wake-Epilepsy Center and Center for Experimental Neurology,
Department of Neurology, Inselspital, University Hospital, University of
Bern, Bern, Switzerland
3Electroencephalography and Epilepsy Unit, Department of Neurology,
University Hospitals of Geneva, Geneva, Switzerland
4ARTORG Center for Biomedical Engineering, University of Bern/Insel
Data Science Center, Inselspital, Bern, Switzerland
5Department of Electronics and Information Systems, Ghent University,
Ghent, Belgium
Corresponding author:
Baudouin Zongxin Jin, Support Center for Advanced Neuroimaging,
Inselspital, Bern, Switzerland; Sleep-Wake-Epilepsy Center and Center
for Experimental Neurology, Department of Neurology, Inselspital,
University Hospital, University of Bern, Bern, Switzerland.
Email: baudouinzongxin.jin@insel.ch
Clinical & Translational Neuroscience
July-December 2020: 1–7





Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use,







































































as a non-epileptic event. In fact, while clinical history,
electroencephalography (EEG), and neuroimaging are fun-
damental to achieve a correct diagnosis, not more than 50%
are diagnosed appropriately.4
EEG is routinely interpreted by visual expert reading for
the presence of epileptic discharges (describes transients
distinguishable from background activity with a character-
istic morphology typically, but neither exclusively nor
invariably, found in interictal EEGs of people with epi-
lepsy.5) If present, an underlying epileptic disorder is very
likely, which indicates a high positive predictive value.
However, the specificity is very low, that is, absence of
spikes does not indicate absence of epilepsy. Thus, alter-
native tools to determine or monitor epilepsy are warranted.
The EEG can be described by physiological or pathological
microstates (so-called spike maps), even in absence of visi-
ble spikes,6 as well as by functional brain connectivity
derived from resting-state EEG without visible spikes,
altered in patients with focal epilepsy.7
Routine magnetic resonance imaging (MRI) has a high
sensitivity to identify structural epileptogenic lesions but
not epileptogenicity.8 Besides, MRI eventually detects
lesions whose entity remains unclear or who are erro-
neously interpreted as possibly epileptogenic.9 Modified
and tailored epilepsy imaging protocols enable neurora-
diologists to detect epileptogenic lesions more reliably.10
Imaging postprocessing is capable to identify visually
obscured morphometric abnormalities in patients with
known disease (mostly temporal lobe epilepsy (TLE)).11,12
Experimental methods targeted to measure direct effects of
electric currents on the magnetic field in the resting brain
have been reported to underline the known diagnosis of
epilepsy and correlated with the outcome after epilepsy
surgery.13 However, none of these studies investigated,
whether there is a diagnostic yield after a first seizure, if
diagnosis of epilepsy is not established. In a previous
review focusing on peri-ictal changes in MRI, 96 publica-
tions were compared and summarized.
Perfusion and diffusion alterations were detected and
reproduced in various anatomical regions, but the patient
cohort was rather small for every finding, with none of
them exceeding 69 patients.8
Since all of the methods mentioned above showed diag-
nostic significance in patients with chronic epilepsy, it is
only reasonable to examine whether these methods can be
an aid at the ED after a first seizure to diagnose and classify
epilepsy. The guidelines14 propose to diagnose epilepsy
even after only one seizure if risk recurrence exceeds
60%.15 Risk stratification still relies on clinical experience,
but there is no biomarker available for risk calculation.16
With our multicenter Swiss study, we aim at identifying
biomarkers in the routine EEG and MRI with newly devel-
oped algorithms, thus facilitating the clinical decision for
or against a particular treatment or further examinations.
For optimal treatment, safety, and life quality of
patients, diagnostic certainty is required, as well as
diagnostic tools that reliably identify epilepsy and potential
underlying lesions.
In the SWISS FIRST trial, we will examine patients with
MRI and EEG in the context of clinical data after a first
probably unprovoked probable seizure, which could be the
first sign of an epileptic disorder. Diagnosis of epilepsy
after a first seizure remains challenging, because there are
no biomarkers available that reliably support diagnosis of
epilepsy versus any other non-epileptic event or acute
symptomatic seizure.
We will implement new strategies of EEG and MRI
acquisition and analysis at the first event. A follow-up of
2 years will determine if the forecast was correct. We will
further stratify whether categorization of the underlying
syndrome (epileptic, cardiac, psychogenic, and other) is
possible after the first event. To our knowledge, this will
be the first large prospective and observational study
regarding first seizures and early-onset epilepsy taking into
account high-quality standard EEG and MRI but also
advanced algorithms.
Study concept
Patients will be recruited starting November 2019 to
November 2021 at the Inselspital Bern, Hôpitaux Univer-
sitaires de Genève, Universitätsspital Zürich, Universitäts-
spital Basel, Kantonsspital St.Gallen, Kantonsspital Aarau,
and Ospedale Civico Lugano. Healthy controls will be
recruited at the Inselspital Bern and in the Hôpitaux Uni-
versitaires de Genève. Patients and healthy controls sign-
informed consent that allows usage of clinical information,
images, and follow-up consultations. All sites received
approval by their respective cantonal ethics committee in
accordance with the declaration of Helsinki. Clinical
decision-making in diagnostics and therapy will be done
independently from the study. Central quantitative data
evaluation will be performed on pseudonymized data only.
Population
Adult patients, who present themselves for the first time at
the ED because of a possible epileptic seizure where an
unprovoked epileptic seizure (idiopathic/unclear etiology,
hereditary, remote symptomatic) has to be ruled out or
ensured, who sign-informed consent, will be included in
this study. In our study, population, therefore, also patients
with unclear events will be included, where in further visits,
a cardiac or psychogenic trigger for the event can possibly
be found. EEG and MRI will be executed if possible the
same day but no later than 7 days after the possible seizure.
Exclusion criteria are as follows:
 history of unprovoked seizure/epilepsy,
 history of provoked seizure within the previous
4 weeks,
 preexisting anticonvulsive medication,
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 inability to perform MRI or EEG, and
 present alcohol dependency (ICD F10.1) and drug
abuse.
If EEG suggests the presence of generalized epilepsy,
which does not require MRI, it will be offered through the
grant, to determine if our tools are capable to differentiate
between focal and generalized epilepsy conditions.
Based on previous epidemiologic data, we expect to
enroll 500–600 patients in total within 24 months.
Matched controls will be selected by the same criteria,
adding only that they shall not have an underlying neuro-
logic or psychiatric disease.
All data will be pseudoanonymized before postprocessing.
Follow-ups
There will be no additional visits outside the clinical
routine. It is the neurologist’s decision, with which fre-
quency patients have to be followed up, whether
relapses occurred and whether antiepileptic treatment
should be initiated or not. We will gather clinical infor-
mation from the reports of every visit and register if
recurrences occurred and if changes regarding treatment
were made. When clinical information is not available
after 2 years, we will contact the patient by telephone to
enquire that information.
Spike maps and microstates
EEGs, obtained as soon as possible after the first event, that
is, within 24–72 h, will be evaluated in a first step conven-
tionally and then quantitatively. We then will focus on the
detailed analysis of microstates during resting EEG, ana-
lyze the resting states, and compare the results with the
control group. Microstates are considered stable topogra-
phies on a subsecond temporal scale and have been used to
describe the EEG in a number of pathologies.17,18 These
basic EEG microstates represent quasi-stable topographies,
which can be described by their frequency of occurrence,
duration, or also their syntax. Interestingly, the basic micro-
states are quite resistant to anesthesia or sleep, which
makes them a particular interesting marker of abnormal
brain activity.19
We will construct a “spike map” using publicly avail-
able software like Cartool (brainmapping.unige.ch/car-
tool). Next to visual identification of the interictal
epileptiform discharges (IEDs), we will use software to
detect them in the EEG and construct the spike topogra-
phy.20 For EEGs without IEDs, in a second step, we aim to
develop a library of possible foci (corresponding to 28 or
more cortex areas), for which possible pathological micro-
states are simulated. This requires the use of advanced head
models to estimate the spike morphology at the scalp level
from sources within cortical areas. The EEGs are then
screened if one or more of these pathological microstates
are present and point to an epileptogenic underlying
process.
Functional connectivity
From the resting EEG, we will extract the whole-brain-
directed functional connectome, first constructing a
patient-specific head model, then parcelling the grey matter
into 82 regions of interests (Figure 1). We will identify
which anatomic structures show altered functional connec-
tivity compared to healthy controls.
Directed functional connectivity (DFC) reveals the
causal influence of one signal (coming from a distinct
region) onto another signal/region within a dedicated net-
work and among different networks. It determines direc-
tional relationships between activities of different brain
regions and reflects short- and long-range interactions of
complex dynamic subsystems that enable information flow
through the human brain. DFC applied to brain sources,
namely source space DFC, revealed, even in the absence
of interictal spikes and seizures, significant connectivity
differences in TLE compared to healthy controls based
on source space DFC during resting state recorded with
high-density EEG,7 suggesting that DFC measures could
serve as a qualitative parameter to determine if the person
suffers from underlying epilepsy or not and, therefore, if
the first seizure needs to be treated or not.
Advanced neuroimaging
All images will be screened for structural epileptogenic
lesion and incidental findings using a dedicated epilepsy
protocol following the guidelines of the International Lea-
gue Against Epilepsy. Diffusion and perfusion MRI is per-
formed to identify potentially transient peri-ictal
abnormalities and their lateralizing value. With the adapta-
tions in MRI first seizure protocols, we intend to detect
possibly all epileptogenic lesions.
Centralized reading of all data will be performed at the
Support Center of Advanced Neuroimaging, Institute of
Diagnostic and Interventional Neuroradiology at the Uni-
versity of Bern. The raters will be preinformed by patient
history, clinical, and EEG findings and will adhere to a
predefined definition of epileptogenic versus non-
epileptogenic lesions by entity.21
Automatic morphometry: Large-scale structural
alterations and networks
Cortical and subcortical brain areas will be automatically
parcellated using the T1 image and the freely available
software FreeSurfer. It distinguishes grey matter, white
matter, blood vessels, ventricles, and scull and measures
volumes and other morphometric parameters such as cor-
tical thickness, surface area, or curvature. These will be
compared to their respective regional normative values,
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correcting for age, sex, magnetic resonance (MR) scanner
and MR sequence. A similar procedure was already per-
formed in the ENIGMA study for epilepsy, which showed
patterns of atrophy for every subtype of epilepsy.11 Now
we will investigate, whether these patterns of atrophy are
already detectable earlier in the progress of disease, namely
after the first seizure and if this pattern already allows a
classification shortly after manifestation.
Neuronal current imaging/phase-cycled stimulus-
induced rotary saturation (NCI/pc-SIRS) in a
population-wide cohort
A newly developed MR sequence (spin locking effects)
will be applied to investigate non-hemodynamic field
effects related to epileptic activity.22 A first technical report
of effects on magnetic field perturbations in a small series
of patients that underwent presurgical phase II workup
reported a hemispheric concordance in seven of eight
patients.13 We will investigate, whether this new sequence
generates reproducible effects in patients after a first sei-
zure and if these findings can support the diagnosis of
epilepsy after the first seizure.
Endpoints of the study: Seizure recurrence prediction
and risk stratification
Two years after the first seizure, patients will be followed
up and relapse(s) of the event will be ascertained. Clinical
evaluation will serve as the ground truth. Information from
advanced neuroimaging, spike maps, functional connectiv-
ity, automatic morphometry, and spin-locking effects will
flow into an artificial intelligence algorithm that shall
dichotomize the possible seizures into epileptic or not. Fur-
ther, it shall determine the probability of seizure recurrence
(Figure 2). Retrospectively, we expect to evaluate whether
there were hints already available after the first seizure that
would have suggested higher seizure recurrence probability
and rank their diagnostic significance.
While it is known that the amount of training data in
supervised learning influences the performance of the mod-
els, determining the exact amount of samples required to
train a classifier is very difficult.23,24 In addition, the effect
size for morphometric differences in patients after a
first seizure is yet unknown. However, the ENIGMA
study11 has found the largest morphometric difference
between patients with unselected chronic epilepsy and
matched healthy controls in the thalami. Using Cohen’s
Figure 1. Pipeline to obtain EEG source connectivity. The EEG signals in sensor space are source imaged using a head model
constructed based on a template- or patient-specific MRI. In the brain ROIs (82 ROIs), the neuronal activity is estimated over time and
fed in the connectivity analysis to obtain the connectivity pattern in source space. EEG: electroencephalography; MRI: magnetic
resonance imaging; ROIs: regions of interest.
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d ¼ 0.37 of the right thalamus, a significance level of
0.05, and a statistical power of 0.80, we estimate to require
at least N ¼ 102 patients and healthy controls to detect a
difference in an unpaired two-sample t-test. To assess the
primary endpoint, models learnt by deep learning networks
need to be tested using a holdout data set of only *20% of
the full data set. Considering this, the project requires to
include at least 510 patients after a first seizure to detect a
significant difference of  < 0.05 and a statistical power
of >0.8.
Discussion
Only with the correct diagnosis and risk stratification, opti-
mal therapy and prevention can be initiated. Preventing
further seizures is the aim of epilepsy therapy, which is
essential for patient safety and which will minimize further
admissions to the ED, lower morbidity, and mortality and
reduce the costs for society. For optimal detection of epi-
leptogenic lesions, it is necessary to acquire dedicated epi-
lepsy protocols.10 With advanced MRI, we expect further
improvement. In the peri- and postictal period especially,
perfusion asymmetries and diffusion restrictions if present
can contribute to the diagnosis of epileptic seizures.8,25
Automatic morphometry can contribute to classification
of epilepsy syndromes.11 Yet, it remains unclear when the
process of atrophy starts and how it differs from normal
aging.26 Our aim is to investigate to which extent atrophy
has already progressed at the time point of the first seizure
and whether categorization of epilepsy syndromes is pos-
sible by identification of distinct atrophy patterns.
In previous studies, spike maps supported diagnosis of
epilepsy even in the absence of interictal discharges.6,27 In
patients with a confirmed history of epilepsy, it is known
that their functional cerebral network differs from healthy
controls.7 This has never been evaluated for patients, where
etiology of seizures remained unclear. To our knowledge,
our study is the first trial to assess, whether network altera-
tions already allow diagnosis of epilepsy after the first
seizure. Furthermore, we will investigate whether antiepi-
leptic drugs affect functional connectivity and whether it is
possible to evaluate if antiepileptic medication is
effective.28
Currently, we have only little experience with detection
of magnetic field oscillations by spin-locking MR tech-
niques. There is evidence from a single study that assessed
postsurgical outcome mainly in patients with TLE.13 The
method identified magnetic field pertubations that were
present ahead of epilepsy surgery and absent after surgery
in patients with favorable clinical outcome. Patients who
suffered from ongoing epileptic seizures presented with
detectable MR abnormalities after surgery.
SWISS FIRST aims to investigate if MR- and EEG-
based image postprocessing may support the diagnosis of
epilepsy already after the first seizure and adds additional
information for classification, risk recurrence, and drug
responsiveness.
There are numerous EEG and MRI trials that describe
alterations in epileptic brains. But there is a lack of knowl-
edge about detectable and early changes in an epileptic
brain after first seizure.8,9 Moreover, longitudinal observa-
tional studies for progress of epilepsy and its damage to the
central nervous system are lacking.8 The study aims to fill
this gap in knowledge to classify epilepsy after a first
seizure.
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Figure 2. Data collection of all seven sites after 2 years. Information and findings from advanced neuroimaging, functional connectivity,
automatic morphometry, and NCI will flow into an artificial intelligence algorithm, developed at the ARTORG/Insel Data Science
Center, the recurrence risk for every information and finding.
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